Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Hatim-Khoja

Hatim-Khoja

King Faisal Specialist Hospital & Research Centre UAE

Zhiwen-Fan

Zhiwen-Fan

Nanjing University Medical School China

Anju-Pradhan

Anju-Pradhan

B.P. Koirala Institute of Health Sciences Nepal

Kumaran-M-Mudaliar

Kumaran-M-Mudaliar

Loyola University Chicago USA

Abbas-Amini

Abbas-Amini

Assistant Professor Western Sydney University Australia

Kenichi-Ohtsubo

Kenichi-Ohtsubo

Professor Niigata University of Pharmacy and Applied Life Sciences Japan

Robert-H-Schiestl

Robert-H-Schiestl

University of California, Los Angeles (UCLA) USA

Shinsuke-Agehara

Shinsuke-Agehara

Assistant Professor, Plant Physiology University of Florida USA

Recommended Global Pathology Webinars & Conferences

Asia Pacific & Middle East
Canada

Euro Pathology 2025

ABOUT

Welcome to the 23rd European Pathology Congress

Date: May 19-20, 2025
Location: London, UK

About the Congress

The 23rd European Pathology Congress convenes a global community of pathologists, researchers, and healthcare professionals to exchange knowledge and advancements in pathology and related disciplines. Key highlights include:

  • Interdisciplinary Collaboration: Bridging science and medicine to advance healthcare through diagnostic innovations and treatment strategies.
  • Cutting-edge Research: Exploring the latest in genetic technologies, clinical trials, and disease profiling to enhance patient care.
  • International Networking: Bringing together leading academics, scientists, and industry experts to foster collaboration and innovation in pathology.

Who Should Attend?

  • Pathologists
  • Microbiologists
  • Oncologists
  • Pharmacists
  • Neurologists
  • Immunologists
  • Therapists
  • Vaccine Developers
  • Dermatologists
  • Epidemiologists
  • Gastroenterologists
  • Ophthalmologists
  • Pediatricians
  • Botanical Pathologists
  • Cardiologists
  • Gynecologists
  • Veterinary Pathologists

Why to Attend the Conference ?

  • Gain insights into cutting-edge research and technologies in pathology.
  • Network with international peers and experts in the field.
  • Discover new advancements and best practices shaping the future of healthcare.
  • Contribute to discussions on global health challenges and solutions.

Join us at the 23rd European Pathology Congress to expand your knowledge, collaborate with peers, and drive innovation in pathology and healthcare.

 

TRACKS

The 23nd European Pathology Congress offers a rich array of sessions and tracks, each dedicated to exploring distinct aspects of pathology and its pivotal impact on healthcare advancement. Participants can select from a breadth of topics, engaging in discussions tailored to their specific interests. Here are the prominent sessions and tracks featured at the congress:

Track 1: Diagnostic Pathology: Diagnostic pathology is at the core of medical practice, playing a pivotal role in disease identification, prognosis, and treatment decisions. The Diagnostic Pathology delves deep into the latest advancements and techniques that empower pathologists to unravel the mysteries of diseases. This designed to enhance your understanding of diagnostic tools, methodologies, and the interpretation of results.

  • Histopathology: Examination of tissues to study the manifestations of disease.
  • Cytopathology: Study of individual cell changes to diagnose conditions.
  • Molecular Pathology: Analysis of molecules within organs, tissues, or bodily fluids to identify genetic and molecular alterations.
  • Clinical Pathology: Lab analysis of body fluids to diagnose and manage disease.
  • Hematopathology: Diagnosis and study of blood-related disorders and diseases.

 

Track 2: Diagnostic Pathology: The Pathology Research at the 22nd European Pathology Congress is dedicated to advancing the frontiers of knowledge in pathology through groundbreaking research and innovative discoveries.

Key areas include

  • Biomarker Discovery, focusing on early diagnosis and personalized treatment.
  • Genomic and Proteomic Analysis, which revolutionizes understanding of diseases at a molecular level.
  • Disease Mechanisms and Pathogenesis, uncovering the foundations of innovative therapies.
  • Immunopathology, highlighting advancements in diagnosing and treating immune-related conditions. Engage with leading researchers, share findings, and gain insights to elevate your research. This track promises a collaborative, cutting-edge experience for professionals dedicated to advancing pathology and improving patient outcomes.

 

Track 3: Digital Pathology and AI : The Digital Pathology and AI explores how digital technologies and artificial intelligence are revolutionizing pathology, enhancing diagnostic precision, and expanding practice capabilities.

  • Artificial Intelligence in Pathology: Explores AI's role in enhancing diagnostic accuracy and efficiency.
  • Telepathology: Focuses on remote pathology diagnosis and consultation via digital platforms.
  • Image Analysis and Pattern Recognition: Examines advanced techniques for automated analysis of pathology images.
  • Pathology Informatics: Covers the integration of data science and informatics in pathology for improved workflow and decision-making.
  • Digital Imaging and Analysis: Utilizes digital technology for capturing, processing, and analyzing medical images, particularly in pathology.

 

Track 4: Infectious Disease Pathology : The Infectious Disease Pathology focuses on the pivotal role of pathology in comprehending and addressing infectious diseases. It convenes pathologists, researchers, and healthcare professionals to investigate pathogen pathology, host responses, emerging infections, and advancements in diagnostics and treatments.

  • Microbiology: Focuses on the study of microorganisms, including bacteria, fungi, and other microscopic organisms relevant to infectious diseases.
  • Virology: Examines viruses, their structure, replication mechanisms, and their role in causing infectious diseases.
  • Parasitology: Investigates parasitic organisms and their interactions with their hosts, studying diseases like malaria and parasitic infections.
  • Emerging Infections: Explores newly identified infectious diseases or the re-emergence of known infections with new epidemiological patterns.
  • Pathogen Identification and Characterization: Involves methods and technologies for identifying and understanding pathogens, crucial for diagnosis, treatment, and prevention strategies in infectious disease pathology.

 

Track 5: Oncologic Pathology:  The Oncologic Pathology highlights pathology's essential role in diagnosing, classifying, and treating cancers. It offers insights into cancer pathology, covering molecular tumor characteristics and personalized treatment innovations. Pathologists, oncologists, and researchers are invited to delve into the latest advancements in cancer diagnosis and treatment strategies.

  • Cancer Diagnosis and Staging: Focuses on methods and criteria used in identifying and classifying cancers, crucial for treatment planning and prognosis.
  • Molecular Oncology: Investigates the molecular mechanisms underlying cancer development and progression, guiding targeted therapies and personalized treatment approaches.
  • Precision Medicine: Utilizes genomic and molecular profiling to tailor treatments based on individual patient characteristics, optimizing therapeutic outcomes.
  • Tumor Microenvironment: Studies interactions between cancer cells and their surrounding environment, influencing tumor growth, metastasis, and response to therapy.
  • Therapeutic Targets: Identifies molecular targets within cancer cells that can be targeted by drugs, aiming to inhibit tumor growth or induce cell death as part of treatment strategies.                                              

 

Track : 6 : Neuropathology : The Neuropathology delves into the intricate field of nervous system pathology, focusing on the diagnosis, understanding, and management of brain and nervous tissue diseases. Pathologists, neurologists, neurosurgeons, and researchers are invited to explore advancements in neuropathology, engage with experts, and share insights into the pathology of brain and nerve-related disorders.

  • Neurodegenerative Diseases: Focuses on disorders like Alzheimer's and Parkinson's, characterized by progressive degeneration of neurons and associated cognitive decline.
  • Brain Tumors: Examines the pathology, classification, and treatment of tumors affecting the brain, including glioma and meningioma.
  • Neuromuscular Pathology: Studies diseases affecting the muscles and nerves, such as muscular dystrophies and neuropathies.
  • Cognitive Pathology: Investigates the pathology underlying cognitive impairments and dementia syndromes.
  • Neuroinfectious Diseases: Explores infections of the nervous system, including viral, bacterial, and parasitic etiologies, impacting neurological function and health.

 

Track 7: Pediatric and Developmental Pathology: The Pediatric and Developmental Pathology  focuses on diseases impacting infants, children, and adolescents. This delves into the molecular foundations of childhood illnesses, clinical management, and advancements in pediatric and developmental pathology. Pathologists, pediatricians, neonatologists, geneticists, and researchers are invited to explore unique challenges and opportunities in pediatric pathology, engage with experts, share insights, and contribute to enhancing care for young patients

  • Congenital and Genetic Disorders: Focuses on inherited and developmental conditions present at birth, studying their pathology and implications for patient care.
  • Perinatal Pathology: Examines conditions affecting fetuses and newborns, including complications during pregnancy, birth defects, and neonatal diseases.
  • Pediatric Hematopathology: Investigates blood disorders in children, including leukemias, lymphomas, and other hematologic malignancies.
  • Developmental Disorders: Studies conditions affecting child development, including neurological and musculoskeletal disorders, impacting developmental milestones and quality of life.
  • Pediatric Tumors: Focuses on the pathology, classification, and treatment of tumors affecting children, including neuroblastoma, Wilms tumor, leukemia, lymphoma, and other pediatric cancers.

 

Track 8: Hematopathology : The Hematopathology track offers a deep dive into hematological diseases, covering blood, bone marrow, and lymphatic tissues. It focuses on diagnosing, classifying, and managing hematological disorders for pathologists, hematologists, and researchers.

  • Hematological Malignancies: Focuses on cancers originating from blood cells or lymphatic tissues, including leukemia, lymphoma, and myeloma.
  • Hematologic Disorders: Covers a wide range of blood disorders such as leukemias, lymphomas, and myeloproliferative disorders, focusing on their pathology and clinical implications.
  • Coagulation and Thrombosis: Investigates disorders of blood clotting and thrombosis, including thrombophilia and bleeding disorders, crucial for understanding hemostasis and thrombosis management.
  • Bone Marrow Pathology: Examines diseases affecting the bone marrow, including myelodysplastic syndromes and bone marrow failure disorders, assessing their impact on blood cell production and function.
  • Hemoglobinopathies: Studies genetic disorders affecting hemoglobin structure or production, such as sickle cell disease and thalassemias, exploring their pathology and management strategies.

 

Track 9: Forensic Pathology : The Forensic Pathology track delves into the critical role of forensic pathology in investigating sudden and unnatural deaths. It provides insights into the methodologies, techniques, and challenges encountered by forensic pathologists. This track invites forensic pathologists, law enforcement professionals, legal experts, and researchers to explore the multifaceted aspects of forensic pathology. Gain knowledge about the investigative methods, technologies, and ethical and legal considerations that influence forensic practice.

  • Post-mortem Examination: Involves the thorough examination of deceased individuals to determine the cause and manner of death.
  • Forensic Autopsy: Detailed examination of the body to gather evidence for legal purposes, such as determining the cause of death in suspicious or criminal cases.
  • Medicolegal Investigations: Combines medical and legal expertise to investigate deaths, ensuring accurate documentation and interpretation of findings.
  • Mass Disaster Identification: Techniques for identifying victims of mass disasters through forensic methods, including DNA analysis and dental records.
  • Expert Witness Testimony: Involves providing professional opinions and interpretations in legal proceedings based on forensic evidence and findings.

 

Track 10: Pathology in Clinical Practice : The Pathology in Clinical Practice track aims to integrate laboratory findings with patient care, highlighting pathology's role in diagnosis, treatment decisions, and overall patient management. Pathologists, clinicians, laboratory professionals, and healthcare administrators are invited to explore how pathology directly impacts clinical settings. Gain valuable insights into how pathology contributes to precise diagnosis, effective patient care, and advancements in medical practices.

  • Laboratory Management: Focuses on overseeing operations, staffing, quality control, and regulatory compliance within clinical pathology laboratories.
  • Quality Assurance and Accreditation: Ensures adherence to standards and guidelines to maintain the accuracy and reliability of laboratory testing and reporting.
  • Reporting and Interpretation: Involves accurately conveying pathology findings to clinicians for informed treatment decisions and patient care.
  • Clinical Case Studies: Examines real-world patient cases to illustrate the role of pathology in diagnosing and managing diseases.
  • Pathology in Patient Care: Explores how pathology findings directly impact patient diagnosis, treatment planning, and overall healthcare outcomes.

Market Analysis

The global pathology laboratories market, valued at USD 311.2 billion in 2021, is expected to expand at a compound annual growth rate (CAGR) of 7.86% from 2022 to 2030. This growth trajectory is driven by the rising demand for early and precise disease diagnosis, advancements in diagnostic technologies, and the increasing prevalence of chronic diseases. Enhanced laboratory capabilities, coupled with the integration of digital pathology and AI-driven diagnostics, are significantly contributing to market expansion. As healthcare systems globally emphasize precision medicine and improved patient outcomes, pathology laboratories play a crucial role in providing critical diagnostic insights and supporting effective treatment decisions, thereby underscoring their importance in the evolving healthcare landscape.

To Collaborate Scientific Professionals around the World

Conference Date May 19-20, 2025

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Clinical & Experimental Pathology Journal of Medical & Surgical Pathology Journal of Cellular & Molecular Pathology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by